ATE306265T1 - Benzothiazolderivate als adenosin-rezeptor- liganden - Google Patents
Benzothiazolderivate als adenosin-rezeptor- ligandenInfo
- Publication number
- ATE306265T1 ATE306265T1 AT02803360T AT02803360T ATE306265T1 AT E306265 T1 ATE306265 T1 AT E306265T1 AT 02803360 T AT02803360 T AT 02803360T AT 02803360 T AT02803360 T AT 02803360T AT E306265 T1 ATE306265 T1 AT E306265T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor ligands
- adenosine receptor
- benzothiazole derivatives
- benzothiazole
- derivatives
- Prior art date
Links
- 102000009346 Adenosine receptors Human genes 0.000 title 1
- 108050000203 Adenosine receptors Proteins 0.000 title 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01127313 | 2001-11-19 | ||
| PCT/EP2002/012543 WO2003043634A1 (en) | 2001-11-19 | 2002-11-09 | Benzothiazole derivatives as adenosine receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE306265T1 true ATE306265T1 (de) | 2005-10-15 |
Family
ID=8179264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02803360T ATE306265T1 (de) | 2001-11-19 | 2002-11-09 | Benzothiazolderivate als adenosin-rezeptor- liganden |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6599901B1 (de) |
| EP (1) | EP1448196B1 (de) |
| JP (1) | JP4216192B2 (de) |
| KR (1) | KR100577109B1 (de) |
| CN (1) | CN100346792C (de) |
| AR (1) | AR037528A1 (de) |
| AT (1) | ATE306265T1 (de) |
| AU (1) | AU2002366194B8 (de) |
| BR (1) | BR0214221A (de) |
| CA (1) | CA2467551A1 (de) |
| DE (1) | DE60206652T2 (de) |
| ES (1) | ES2249639T3 (de) |
| GT (1) | GT200200233A (de) |
| MX (1) | MXPA04004683A (de) |
| PA (1) | PA8557901A1 (de) |
| PE (1) | PE20030715A1 (de) |
| PL (1) | PL369470A1 (de) |
| RU (1) | RU2295523C2 (de) |
| TW (1) | TW200407137A (de) |
| UY (1) | UY27543A1 (de) |
| WO (1) | WO2003043634A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| US6727247B2 (en) * | 2001-12-10 | 2004-04-27 | Hoffman-La Roche Inc. | Substituted benzothiazole amide derivatives |
| EP3473251B1 (de) | 2002-12-20 | 2023-12-13 | NicoNovum AB | Nikotin-cellulose-kombination |
| WO2005028484A1 (en) | 2003-09-19 | 2005-03-31 | F. Hoffmann-La Roche Ag | Thiazolopyridine derivatives as adenosine receptor ligands |
| EP1677791A4 (de) | 2003-10-31 | 2007-08-15 | Takeda Pharmaceutical | Stickstoffhaltige kondensierte heterocyclische verbindungen |
| JP2008506735A (ja) | 2004-07-22 | 2008-03-06 | エフ．ホフマン−ラ ロシュ アーゲー | 置換されているベンゾチアゾール類 |
| MX2007000638A (es) * | 2004-07-22 | 2007-03-07 | Hoffmann La Roche | Derivados de benzotiazol. |
| ES2273599B1 (es) * | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
| CA2646942C (en) | 2006-03-16 | 2014-07-29 | Modoral Brands Inc. | Improved snuff composition |
| WO2008063301A2 (en) * | 2006-10-11 | 2008-05-29 | Alpharma, Inc. | Pharmaceutical compositions |
| JP5097265B2 (ja) * | 2007-04-04 | 2012-12-12 | メルク・シャープ・エンド・ドーム・コーポレイション | 治療薬 |
| US9549909B2 (en) | 2013-05-03 | 2017-01-24 | The Katholieke Universiteit Leuven | Method for the treatment of dravet syndrome |
| KR20180095674A (ko) | 2015-12-22 | 2018-08-27 | 조게닉스 인터내셔널 리미티드 | 대사 저항성 펜플루라민 유사체 및 그 사용 방법 |
| PL3800177T3 (pl) | 2015-12-22 | 2025-05-19 | Zogenix International Limited | Kompozycje fenfluraminy i sposoby ich wytwarzania |
| EP3518975B1 (de) | 2016-08-24 | 2025-04-09 | Zogenix International Limited | Formulierung bestehend aus fenfluramine und cannabidiol und deren verwendung in der behandlung von epilepsie |
| US10682317B2 (en) | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
| JP2021526507A (ja) | 2018-05-11 | 2021-10-07 | ゾゲニクス インターナショナル リミテッド | 発作により誘発される突然死を処置するための組成物および方法 |
| EP3806835A1 (de) * | 2018-06-14 | 2021-04-21 | Zogenix International Limited | Zusammensetzungen und verfahren zur behandlung von atemdepression mit fenfluramin |
| US12144787B2 (en) | 2018-11-19 | 2024-11-19 | Zogenix International Limited | Method of treating patients with a mutation in cyclin-dependent kinase-like 5 (CDKL5) |
| DE102019110904B4 (de) | 2019-04-26 | 2022-01-20 | Helmholtz-Zentrum Dresden - Rossendorf E. V. | N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung |
| US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3374550D1 (en) | 1982-12-21 | 1987-12-23 | Johnsen Jorgensen Plastics Ltd | Dispensing container |
| IL90337A0 (en) * | 1988-05-24 | 1989-12-15 | Pfizer | Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents |
| DE60132777T2 (de) * | 2000-06-21 | 2009-02-12 | F. Hoffmann-La Roche Ag | Benzothiazolderivate zur behandlung von alzheimer und parkinson |
-
2002
- 2002-11-05 US US10/288,531 patent/US6599901B1/en not_active Expired - Fee Related
- 2002-11-09 PL PL02369470A patent/PL369470A1/xx not_active Application Discontinuation
- 2002-11-09 JP JP2003545315A patent/JP4216192B2/ja not_active Expired - Fee Related
- 2002-11-09 DE DE60206652T patent/DE60206652T2/de not_active Expired - Fee Related
- 2002-11-09 CA CA002467551A patent/CA2467551A1/en not_active Abandoned
- 2002-11-09 ES ES02803360T patent/ES2249639T3/es not_active Expired - Lifetime
- 2002-11-09 AT AT02803360T patent/ATE306265T1/de not_active IP Right Cessation
- 2002-11-09 BR BR0214221-0A patent/BR0214221A/pt not_active IP Right Cessation
- 2002-11-09 CN CNB028228901A patent/CN100346792C/zh not_active Expired - Fee Related
- 2002-11-09 AU AU2002366194A patent/AU2002366194B8/en not_active Ceased
- 2002-11-09 MX MXPA04004683A patent/MXPA04004683A/es active IP Right Grant
- 2002-11-09 RU RU2004118423/04A patent/RU2295523C2/ru not_active IP Right Cessation
- 2002-11-09 WO PCT/EP2002/012543 patent/WO2003043634A1/en not_active Ceased
- 2002-11-09 EP EP02803360A patent/EP1448196B1/de not_active Expired - Lifetime
- 2002-11-09 KR KR1020047007646A patent/KR100577109B1/ko not_active Expired - Fee Related
- 2002-11-14 TW TW091133382A patent/TW200407137A/zh unknown
- 2002-11-14 PA PA20028557901A patent/PA8557901A1/es unknown
- 2002-11-15 PE PE2002001103A patent/PE20030715A1/es not_active Application Discontinuation
- 2002-11-15 AR ARP020104398A patent/AR037528A1/es not_active Application Discontinuation
- 2002-11-18 GT GT200200233A patent/GT200200233A/es unknown
- 2002-11-18 UY UY27543A patent/UY27543A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1589146A (zh) | 2005-03-02 |
| AR037528A1 (es) | 2004-11-17 |
| JP2005515980A (ja) | 2005-06-02 |
| UY27543A1 (es) | 2003-05-30 |
| WO2003043634A1 (en) | 2003-05-30 |
| MXPA04004683A (es) | 2004-08-12 |
| KR100577109B1 (ko) | 2006-05-10 |
| AU2002366194B2 (en) | 2006-10-26 |
| DE60206652T2 (de) | 2006-06-22 |
| AU2002366194B8 (en) | 2006-11-16 |
| JP4216192B2 (ja) | 2009-01-28 |
| EP1448196A1 (de) | 2004-08-25 |
| PE20030715A1 (es) | 2003-08-29 |
| KR20050044537A (ko) | 2005-05-12 |
| DE60206652D1 (de) | 2006-02-23 |
| TW200407137A (en) | 2004-05-16 |
| AU2002366194A1 (en) | 2003-06-10 |
| CN100346792C (zh) | 2007-11-07 |
| ES2249639T3 (es) | 2006-04-01 |
| CA2467551A1 (en) | 2003-05-30 |
| BR0214221A (pt) | 2004-09-21 |
| US6599901B1 (en) | 2003-07-29 |
| RU2004118423A (ru) | 2006-01-10 |
| PA8557901A1 (es) | 2003-06-30 |
| PL369470A1 (en) | 2005-04-18 |
| EP1448196B1 (de) | 2005-10-12 |
| GT200200233A (es) | 2003-06-17 |
| RU2295523C2 (ru) | 2007-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE306265T1 (de) | Benzothiazolderivate als adenosin-rezeptor- liganden | |
| HUS1500055I1 (hu) | HIV-gátló pirimidinszármazékok | |
| ATE450528T1 (de) | Chinazolinderivate als antitumormittel | |
| DE602004015724D1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
| DK1414440T3 (da) | N-phenylpyrrolguanidinderivater som melanocortinreceptorligander | |
| ATE338041T1 (de) | Thiazolderivate als phosphodiesterase iv- inhibtoren | |
| ATE391505T1 (de) | Benzothiazole derivative | |
| ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
| DE60330372D1 (de) | Indol-3-schwefelderivate | |
| IS7720A (is) | Píperidín-N-oxíð-afleiður | |
| DK1474408T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
| EE200300447A (et) | Asendatud bensofuraan-2-karboksamiidide derivaadid | |
| DE60307512D1 (de) | 3h-chinazoline -4-on derivaten | |
| ATE325123T1 (de) | Imidazoquinoline derivate als adenosine a3 rezeptor liganden | |
| DE60203820D1 (de) | Pyridinderivate als nmda-rezeptorliganden | |
| ATE423771T1 (de) | Tetrahydrochinolinderivate | |
| NO20043119L (no) | Triazolokinolinderivater som kan anvendes som adenosinreseptorligander | |
| ATE394372T1 (de) | G-lactamderivate als prostaglandinagonisten | |
| ATE281456T1 (de) | Aminotriazolopyridinderivate als adenosinrezeptorliganden | |
| DE60214408D1 (de) | 5-METHOXY-8-ARYL-i1,2,4öTRIAZOLOi1,5-AöPYRIDINE DERIVATIVE ALS ADENOSIN-REZEPTOR ANTAGONISTEN | |
| DE60212694D1 (de) | Benzothiazolderivaten | |
| ATE389652T1 (de) | Benzothiazol-derivate als liganden des adenosinrezeptors | |
| ATE346045T1 (de) | Heteroaryl-substituierte aminocyclohexan-derivate | |
| ATE382601T1 (de) | Substituierte 4-aminocyclohexanolderivate | |
| ATE370947T1 (de) | 7-((1,4)dioxan-2-yl)-benzothiazol derivative als adenosin-rezeptoren liganden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1448196 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |